Health-Related Quality of Life and Metabolic Outcomes in PCOS

Recruiting now · Not applicable

Conditions studied: PCOS (Polycystic Ovary Syndrome)

In brief

The primary outcome of interest is change in PCOS health-related quality of life, while the secondary outcome of interest is change in adiposity, cardiometabolic, and inflammation biomarkers.

Key facts

Study ID

NCT07571915

Run by

The Cleveland Clinic

People needed

40

Starts

2026-06-01

Expected to finish

2027-12-31

Last updated by the study team

2026-07-01

Who can join

Age: 18 and older, up to 49. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Non-pregnant females ages 18-49 years
• Preexisting diagnoses of PCOS and obesity (body-mass index (BMI) equal or greater to 30 kg/m2) at enrollment

You may not qualify if…

• Patients who are pregnant or planning to become pregnant during the study period
• Patients currently or with recent participation (< 12 months at the time of enrollment) in a PCOS-focused group
• Patients with documented monogenic obesity
• Patients with a diagnosis of any type of diabetes (with the exclusion of prediabetes)
• Patients on systemic glucocorticoid therapy > 7 days at the time of enrollment
• Patients with any end-stage organ disease
• Patients without access to internet
• Patients requiring English language interpretation
• Any condition which, based on the investigator's medical judgment, would preclude patient ability to complete the study

Where it is running

• Cleveland Clinic — Cleveland, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.